Literature DB >> 9639285

Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

C Zona1, A Siniscalchi, N B Mercuri, G Bernardi.   

Abstract

The actions of the neuroprotective and anticonvulsant agent riluzole on voltage-activated currents were studied in primary cultures of rat cortical neurons by using whole-cell patch-clamp recording techniques. Isolated Na+, Ca2+ and K+ currents were generated in these cells by depolarizing commands from a holding potential of - 80 mV. Riluzole (10-300 microM) reversibly reduced in a dose-dependent manner the inward Na+ currents with an IC50 of 51 microM in all the tested neurons (n=29). This drug also shifted the steady-state inactivation curve of the sodium current towards more negative values (about 20mV, n=15) while it did not change significantly the decay phase of the Na+ current. Furthermore, riluzole (100 and 300 microM; n=5 and n=3, respectively) did not modulate the inward Ca2+ currents evoked by depolarizing steps on cortical cells. An additional concentration-dependent effect of riluzole was observed on the outward potassium currents. In fact, while the amplitude of the peak of the outward current (IA) was not changed significantly, the amplitude of the late component of the outward K+ current (Iss) was markedly decreased during the perfusion of riluzole (IC50=88 microM; n=16). It is concluded that riluzole modulates the Na+- and the late K+-dependent currents in cortical neurons. Both phenomena may explain, at least in part, the anticonvulsant and neuroprotective properties of this compound.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639285     DOI: 10.1016/s0306-4522(97)00604-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

1.  Essential role of the persistent sodium current in spike initiation during slowly rising inputs in mouse spinal neurones.

Authors:  J J Kuo; R H Lee; L Zhang; C J Heckman
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

2.  Riluzole in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice.

Authors:  Masanori Ohashi; Akiyoshi Saitoh; Misa Yamada; Jun-Ichiro Oka; Mitsuhiko Yamada
Journal:  Psychopharmacology (Berl)       Date:  2014-08-17       Impact factor: 4.530

3.  Effects of riluzole on electrically evoked neurotransmitter release.

Authors:  T Jehle; J Bauer; E Blauth; A Hummel; M Darstein; T M Freiman; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Metabotropic glutamate receptors (mGluR5) activate transient receptor potential canonical channels to improve the regularity of the respiratory rhythm generated by the pre-Bötzinger complex in mice.

Authors:  Faiza Ben-Mabrouk; Louella B Amos; Andrew K Tryba
Journal:  Eur J Neurosci       Date:  2012-05-22       Impact factor: 3.386

5.  Characteristics of hippocampal glycine release in cell-damaging conditions in the adult and developing mouse.

Authors:  P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

6.  Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.

Authors:  Ananthakrishnan Sankaranarayanan; Girija Raman; Christoph Busch; Tim Schultz; Pavel I Zimin; Joachim Hoyer; Ralf Köhler; Heike Wulff
Journal:  Mol Pharmacol       Date:  2008-10-27       Impact factor: 4.436

7.  Activation of glutamate transporters in the locus coeruleus paradoxically activates descending inhibition in rats.

Authors:  Ken-ichiro Hayashida; Renee A Parker; James C Eisenach
Journal:  Brain Res       Date:  2010-01-06       Impact factor: 3.252

Review 8.  Riluzole in the treatment of mood and anxiety disorders.

Authors:  Christopher Pittenger; Vladimir Coric; Mounira Banasr; Michael Bloch; John H Krystal; Gerard Sanacora
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report.

Authors:  Amber Cardoos; Aya Inamori; Gerard Sanacora; Maurizio Fava; David Mischoulon
Journal:  Psychosomatics       Date:  2013-03-06       Impact factor: 2.386

10.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.